Effectdossier · gearchiveerd kwartaal
MRNA
Moderna, Inc. · Healthcare · Biotechnology
15Gevolgde houders
0Δ houders
160.48MGehouden aandelen
$4.43BGerapporteerde waarde
+1Nieuwe posities
−1Uitstappen
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +0.4% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 147 | +2 | 264.33M | $18.50B | +8 | −5 |
| Q1 2026 | 147 | +3 | 253.55M | $12.87B | +6 | −4 |
| Q4 2025 | 144 | +3 | 257.18M | $7.59B | +5 | −1 |
| Q3 2025 | 18 | +1 | 165.07M | $4.26B | +2 | −2 |
| Q2 2025 | 15 | 0 | 160.48M | $4.43B | +1 | −1 |
| Q1 2025 | 12 | -2 | 69.84M | $1.98B | +1 | −3 |
| Q4 2024 | 14 | -1 | 78.84M | $3.28B | +3 | −4 |
| Q3 2024 | 14 | -2 | 62.86M | $4.20B | +2 | −4 |
| Q2 2024 | 16 | — | 65.32M | $7.75B | — | — |
Wie het bezit · Q2 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 41.71M | — | $1.15B | 0.0% | n/c | 1 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passief) | 41.71M | — | $1.15B | 0.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passief) | 41.71M | — | $1.15B | 0.0% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passief) | 41.71M | — | $1.15B | 0.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passief) | 41.71M | — | $1.15B | 0.0% | n/c | 1 | SEC ↗ |
| 6 | The Vanguard Group ✦ (passief) | 41.71M | — | $1.15B | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 28.61M | — | $789.39M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 28.61M | — | $789.39M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 28.61M | — | $789.39M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 28.61M | — | $789.39M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 28.61M | — | $789.39M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 28.61M | — | $789.39M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 28.61M | — | $789.39M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 28.61M | — | $789.39M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 28.61M | — | $789.39M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 28.61M | — | $789.39M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 28.61M | — | $789.39M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 28.61M | — | $789.39M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (passief) | 28.61M | — | $789.39M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (passief) | 28.61M | — | $789.39M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (passief) | 28.61M | — | $789.39M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (passief) | 28.61M | — | $789.39M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | BlackRock ✦ (passief) | 28.61M | — | $789.39M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | BlackRock ✦ (passief) | 28.61M | — | $789.39M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | BlackRock ✦ (passief) | 28.61M | — | $789.39M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | BlackRock ✦ (passief) | 28.61M | — | $789.39M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | BlackRock ✦ (passief) | 28.61M | — | $789.39M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Baillie Gifford ✦ | 22.09M | -11.4% | $609.58M | 0.5% | ▼ Trim | 5 | SEC ↗ |
| 29 | Baillie Gifford ✦ | 22.09M | -11.4% | $609.58M | 0.5% | ▼ Trim | 5 | SEC ↗ |
| 30 | Baillie Gifford ✦ | 22.09M | -11.4% | $609.58M | 0.5% | ▼ Trim | 5 | SEC ↗ |
| 31 | Baillie Gifford ✦ | 22.09M | -11.4% | $609.58M | 0.5% | ▼ Trim | 5 | SEC ↗ |
| 32 | Fidelity (FMR) ✦ | 19.65M | — | $542.02M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Fidelity (FMR) ✦ | 19.65M | — | $542.02M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Fidelity (FMR) ✦ | 19.65M | — | $542.02M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Fidelity (FMR) ✦ | 19.65M | — | $542.02M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Fidelity (FMR) ✦ | 19.65M | — | $542.02M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | State Street Global Advisors ✦ (passief) | 17.27M | -2.9% | $476.50M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 38 | Geode Capital Management ✦ (passief) | 8.88M | +19.1% | $244.46M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | Geode Capital Management ✦ (passief) | 8.88M | +19.1% | $244.46M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 40 | D. E. Shaw & Co. ✦ | 7.46M | +32.4% | $205.92M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 41 | D. E. Shaw & Co. ✦ | 7.46M | +32.4% | $205.92M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 42 | Two Sigma Investments ✦ | 6.96M | +56.2% | $192.00M | 0.4% | ▲ Add | 5 | SEC ↗ |
| 43 | Norges Bank ✦ (passief) | 3.44M | +25.6% | $94.91M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 44 | Citadel Advisors ✦ | 1.83M | +4.2% | $50.62M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 45 | Citadel Advisors ✦ | 1.83M | +4.2% | $50.62M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 46 | Renaissance Technologies ✦ | 1.00M | -26.2% | $27.70M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 47 | Millennium Management ✦ | 869.49K | +484.4% | $23.99M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 48 | T. Rowe Price ✦ | 624.16K | -2.9% | $17.22M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 49 | T. Rowe Price ✦ | 624.16K | -2.9% | $17.22M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 50 | Wellington Management ✦ | 38.80K | -98.7% | $1.07M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 51 | Gotham Asset Management ✦ | 33.98K | Nieuw | $937,563 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Gotham Asset Management | $937,563 | 0.0% |
Verlaten
| AQR Capital Management | $415,195 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 717 houders, 306.78M aandelen, $15.39B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q2 2025 ·
Methodologie ·
Verkrijg dit via de API